Valuation: AroCell AB

Market Cap 89.38M 9.01M 7.91M 7.47M 6.81M 12.74M 864M 12.83M 34.62M 441M 33.84M 33.11M 1.42B P/E 2024
-2.12x
P/E 2025 -6.69x
Enterprise Value 66.04M 6.66M 5.84M 5.52M 5.03M 9.41M 638M 9.48M 25.58M 326M 25M 24.46M 1.05B EV / Sales 2024
0.73x
EV / Sales 2025 1.09x
Free-Float
68.85%
Yield 2024 *
-
Yield 2025 -
1 day-1.52%
1 week-0.51%
Current month-1.52%
1 month-2.76%
3 months-10.39%
6 months+23.57%
Current year+9.92%
1 week 0.37
Extreme 0.373
0.4
1 month 0.37
Extreme 0.373
0.45
Current year 0.25
Extreme 0.25
0.53
1 year 0.25
Extreme 0.25
0.53
3 years 0.25
Extreme 0.25
0.66
5 years 0.25
Extreme 0.25
2.4
10 years 0.25
Extreme 0.25
8.45
Manager TitleAgeSince
Chief Executive Officer - 2026-05-27
Director of Finance/CFO - 2022-08-17
Chief Tech/Sci/R&D Officer - 2024-12-31
Director TitleAgeSince
Director/Board Member 56 2019-12-31
Chairman 39 2024-05-21
Director/Board Member 74 2022-12-31
Date Insider Type Main position Quantity % Market Cap. Importance
9/2/21 Buy

Executive/Senior Manager

25,000 0.0220%
9/2/21 Buy 20,000 0.0176%
9/1/21 Buy

Director

5,353 0.0047%
Change 5-day change 1-year change 3-year change Capi.($)
-1.52%-0.51%-3.00%-24.22% 9.12M
-0.14%+4.44%+8.50%+33.52% 48.01B
-1.69%+0.35%+49.18%+36.04% 45.27B
+0.24%+2.09%+9.40%+89.34% 40.93B
+2.56%+4.08%+370.76%+583.23% 42.84B
-0.62%-1.61%+5.30%+46.02% 29.6B
-0.28%+0.60%+24.44%+155.01% 17.32B
-0.46%+0.62%+24.98%+41.01% 15.34B
-2.21%-5.62% - - 15.15B
+3.37%+5.79%+7.30% - 14.84B
Average -0.19%+1.02%+55.21%+119.99% 26.93B
Weighted average by Cap. +0.00%+1.56%+78.59%+152.76%

Financials

2024 2025
Net sales 57.44M 5.79M 5.08M 4.8M 4.37M 8.19M 555M 8.25M 22.25M 284M 21.74M 21.27M 911M 53.11M 5.36M 4.7M 4.44M 4.04M 7.57M 513M 7.63M 20.57M 262M 20.11M 19.67M 843M
Net income -42.45M -4.28M -3.76M -3.55M -3.23M -6.05M -410M -6.09M -16.44M -210M -16.07M -15.72M -674M -12.15M -1.23M -1.08M -1.02M -925K -1.73M -117M -1.74M -4.71M -59.99M -4.6M -4.5M -193M
Net Debt -47.78M -4.82M -4.23M -3.99M -3.64M -6.81M -462M -6.86M -18.51M -236M -18.09M -17.7M -758M -23.34M -2.35M -2.06M -1.95M -1.78M -3.33M -226M -3.35M -9.04M -115M -8.84M -8.64M -370M
Logo AroCell AB
IDL Diagnostics AB (publ), formerly AroCell AB (publ), is a Sweden-based diagnostic Company engaged in the biotechnology and medical diagnostics industry. The Company focuses on research, development, manufacturing, and commercialization of diagnostic and medical technology products. The Company has a broad product portfolio of In Vitro Diagnostics (IVD) tests that deliver clinical information for the detection of disease with indications spanning everything from urological cancers to typhoid fever. IDL Diagnostics AB (publ) develops tests that are clinically useful and economically viable. The Company provides rapid tests, laboratory tests and platform tests that improve decision making and are non-invasive, cost effective, as well as easy to perform.
Employees
25
Date Price Change Volume
26-09-25 SEK 0.3880 -1.52% 44,027
26-09-24 SEK 0.3940 +4.79% 17,668
26-09-23 SEK 0.3760 -3.34% 16,766
26-09-22 SEK 0.3890 +4.01% 171,026
26-09-21 SEK 0.3740 -5.32% 404,902

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IDLDX Stock